Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from the US Food and Drug Administration

No clear answers on antidepressants in pregnancy

The US Food and Drug Administration recently convened a panel of experts to examine a sensitive and increasingly urgent question: should antidepressants be prescribed to women suffering from depression during pregnancy?

The Conversation

Married couple whose home was bursting with truckloads of illegal sex pills sentenced

Eduard Yusupov and Diana Fuzailov sold sexual enhancement products online via their company Love Potion, Inc., claiming them to be made from natural ingredients

The Independent UK

Sarepta's Shocking Stand: Company Rejects FDA Request To Pull Gene Therapy Elevidys

The ground shook for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) last week as the U.S. Food and Drug Administration (FDA), alarmed by a third patient death tied to its gene therapy platform, pulled a rare move: requesting a voluntary halt to Elevidys shipments. The company’s response? A resounding “no,” igniting a major…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

3-Parent Babies Born Healthy in the U.K.

The FDA blocked a similar successful treatment for mitochondrial disease a quarter of century ago.

Reason

US Authorizes Juul To Market Vaping Products

Juul Labs said Thursday that the US Food and Drug Administration had officially authorized the e-cigarette maker to market its vaping system and refill capsules in the United States.

International Business Times

Why Is Milestone Pharmaceuticals Stock Plunging On Friday?

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) moved closer to potential FDA approval for its Cardamyst (etripamil) nasal spray, an investigational therapy for paroxysmal supraventricular tachycardia (PSVT), as the U.S. Food and Drug Administration (FDA) accepted the company’s response to prior issues.

Benzinga

US Approves Gilead's Twice-yearly Injection To Prevent HIV

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hailed as a major breakthrough in the fight against the sexually transmitted virus.

International Business Times

Read news from The Economist, FT, and more,
with one subscription

Diabetics at Risk: FDA Issues Highest-Level Recall on 2M Dexcom Devices Over 'Deadly Fault'

The FDA has recalled 2 million Dexcom glucose monitors due to a serious safety risk. Learn how diabetic patients should act immediately to protect their health.

International Business Times UK

RFK Jr. will ‘end the war’ against alternative medicine at the FDA, from stem cell therapy to chelation

“If you want to take an experimental drug … you ought to be able to do that," said RFK Jr.

Fortune

Cardiologists are begging you to never practice this mid-morning habit

Reaching for the caffeine can backfire for some people

The Independent UK

US grocery chain recalls baby food pouches due to possible lead contamination

There is no safe level of exposure to lead for children, according to the U.S. Centers for Disease Control and Prevention

The Independent UK

I wish I’d known about this freezer coin hack before — now I know if my food is safe to eat

Discover the coin hack that checks whether your freezer is keeping your food safe.

Tom’s Guide

RFK Jr. Is Giving Families 'False Hope' By Claiming He'll Figure Out Cause of Autism by September, Former FDA Vaccine Head Warns

Dr. Peter Marks criticized RFK Jr. for giving what he called "false hope" to families by claiming that the cause of autism will be identified by September.

Medical Daily

RFK Jr. Is Giving Families 'False Hope' By Claiming He'll Figure Out Cause of Autism by September, Former FDA Vaccine Head Warns

Dr. Peter Marks criticized RFK Jr. for giving what he called "false hope" to families by claiming that the cause of autism will be identified by September.

Latin Times

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Animal tranquilizers found in illegal opioids may suppress the lifesaving medication naloxone − and cause more overdose deaths

The animal tranquilizers xylazine and medetomidine are in approximately one-third of the illegal opioids available in the U.S., including fentanyl, heroin and oxycodone. Animal tranquilizers enhance the user’s euphoric high from opioids, particularly in those who have developed a tolerance to the opioid. But adding the tranquilizers to these already…

PetsRadar

Further cat food recalled amid bird flu concerns with more cats falling ill

The US Food and Drug Administration has recalled a further four products

Latin Times

Girl Scouts Asserts Cookies Are 'Trusted' After Joe Rogan Blasts the Treats as 'Toxic' Over Disputed Ingredients Report

The Girl Scouts responded accusations from Joe Rogan, alleging that cookies being sold by the youth organization contain toxic, harmful ingredients.

Fortune

RFK Jr. drinks raw milk—as do many others, spending up to $21 a gallon. What are the risks and benefits?

The dairy product has gotten lots of attention lately. Here's what we know about unpasteurized milk.

Get all your
news in one place.

100's of premium titles.
One news app.

The Times of India

FDA issues highest risk level recall for over 6,000 tubs of protein powder

Controversies around protein powder refuse to stop. A week after findings of a study suggested presence of heavy metals in protein powders, a renowned protein powder brand Orgain has issued a voluntary recall of its chocolate-flavored “30g Plant Protein Complete Protein Powder” due to undeclared peanut allergens. The US Food…

StockNews.com

3 Pharmaceutical Stocks Addressing Global Health Challenges

With the recent rise of diseases, pharmaceutical companies are pushing boundaries in medicine, from life-saving treatments to pioneering global healthcare solutions. Hence, investing in established pharmaceutical stocks, Pfizer (PFE), Johnson & Johnson (JNJ), and Merck & Co. (MRK) presents a compelling opportunity to capitalize for the long term. Read more.

The Independent UK

The US Food and Drug Administration said taking wrong dose of Clonazepam could result in ‘significant sedation, confusion, dizziness, diminished reflexes, ataxia, and hypotonia’

The Conversation

A common nasal decongestant lacks evidence but is still sold in the UK

For years, the drug phenylephrine has been a popular choice for relieving nasal congestion, however, the US Food and Drug Administration (FDA) is considering removing oral phenylephrine medicines from pharmacy shelves. Recent FDA findings suggest it lacks effectiveness.

The Conversation

Eight conditions weight-loss jabs might be beneficial for

The weight-loss jab Wegovy made its debut on June 4 2021. It was the first new weight-loss drug to be approved by the US Food and Drug Administration since 2014.

The Independent UK

The Apple AirPods update that could help millions who didn’t know they needed it

An Apple update has been welcomed by hearing experts

StockNews.com

3 Biotech Stocks Set to Revolutionize Medicine

The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To capitalize on the industry’s expansion, it could be wise to invest in fundamentally sound biotech stocks, Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), and Biogen (BIIB), which have the potential to revolutionize medicine. Read…

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Centers for Disease Control and Prevention

322 stories

Pfizer Inc

315 stories

Health and Human Services

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.